Tongai Maponga

5.1k total citations
35 papers, 528 citations indexed

About

Tongai Maponga is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Tongai Maponga has authored 35 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Epidemiology, 25 papers in Hepatology and 18 papers in Infectious Diseases. Recurrent topics in Tongai Maponga's work include Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (9 papers). Tongai Maponga is often cited by papers focused on Hepatitis B Virus Studies (27 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (9 papers). Tongai Maponga collaborates with scholars based in South Africa, United Kingdom and United States. Tongai Maponga's co-authors include Wolfgang Preiser, Monique Andersson, Philippa C. Matthews, Jolynne Mokaya, Anna McNaughton, Janet Seeley, Geraldine O’Hara, Richard S. Tedder, Samreen Ijaz and Sandra Meredith and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and International Journal of Molecular Sciences.

In The Last Decade

Tongai Maponga

32 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tongai Maponga South Africa 15 380 344 209 42 27 35 528
Georgina Ireland United Kingdom 9 168 0.4× 129 0.4× 154 0.7× 37 0.9× 17 0.6× 24 325
Clement Gascua Adu-Gyamfi South Africa 10 203 0.5× 130 0.4× 177 0.8× 8 0.2× 40 1.5× 17 413
Joan M. Block United States 11 436 1.1× 377 1.1× 50 0.2× 24 0.6× 17 0.6× 19 498
Meredith Reilly United States 6 243 0.6× 167 0.5× 104 0.5× 61 1.5× 7 0.3× 10 311
Linh‐Vi Le Philippines 10 207 0.5× 140 0.4× 96 0.5× 12 0.3× 6 0.2× 19 257
Yi‐Chia Huang Taiwan 11 178 0.5× 161 0.5× 164 0.8× 12 0.3× 13 0.5× 20 301
Diane Goodwin United States 7 186 0.5× 167 0.5× 164 0.8× 5 0.1× 8 0.3× 8 403
Kristin Sweet United States 7 201 0.5× 160 0.5× 59 0.3× 83 2.0× 5 0.2× 9 295
Xiaoying Ma China 7 182 0.5× 126 0.4× 30 0.1× 17 0.4× 29 1.1× 19 339
Gyde Steffen Germany 7 150 0.4× 60 0.2× 63 0.3× 13 0.3× 55 2.0× 15 230

Countries citing papers authored by Tongai Maponga

Since Specialization
Citations

This map shows the geographic impact of Tongai Maponga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tongai Maponga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tongai Maponga more than expected).

Fields of papers citing papers by Tongai Maponga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tongai Maponga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tongai Maponga. The network helps show where Tongai Maponga may publish in the future.

Co-authorship network of co-authors of Tongai Maponga

This figure shows the co-authorship network connecting the top 25 collaborators of Tongai Maponga. A scholar is included among the top collaborators of Tongai Maponga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tongai Maponga. Tongai Maponga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirk, Gregory D., Jim Aizire, Jackson Orem, et al.. (2025). Pragmatic Approach to Hepatocellular Carcinoma Diagnosis in High-Incidence, Resource-Limited Settings in Africa. JCO Global Oncology. 11(11). e2400592–e2400592.
2.
Tshiabuila, Derek, James Emmanuel San, Eduan Wilkinson, et al.. (2025). Conserved recombination patterns across hepatitis B genotypes: a retrospective study. Virology Journal. 22(1). 220–220.
3.
Parker, Arifa, Tongai Maponga, Shubhangi R. Parkar, et al.. (2025). Pre-existing adipose tissue signaling profile related to obesity determines disease outcome of COVID-19: addressing obesity should be a priority for future pandemic preparedness. Frontiers in Endocrinology. 16. 1506065–1506065.
4.
Tshiabuila, Derek, Wonderful T. Choga, James Emmanuel San, et al.. (2024). An Oxford Nanopore Technology-Based Hepatitis B Virus Sequencing Protocol Suitable for Genomic Surveillance Within Clinical Diagnostic Settings. International Journal of Molecular Sciences. 25(21). 11702–11702. 1 indexed citations
5.
Zyl, Gert U. van, et al.. (2024). The role of new hepatitis B vaccines in South Africa. South African Medical Journal. 114(2). e1473–e1473. 1 indexed citations
6.
Mohammed, Khadija Said, Louise Downs, Sheila Lumley, et al.. (2024). Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection. ˜The œLancet. Gastroenterology & hepatology. 9(4). 383–392. 9 indexed citations
7.
Maponga, Tongai, Marije Van Schalkwyk, Susan Hugo, et al.. (2023). Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa. Journal of Virus Eradication. 9(1). 100317–100317. 4 indexed citations
8.
Maponga, Tongai, Houriiyah Tegally, Andrew D. Sutherland, et al.. (2022). Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection With accumulation of mutations in a patient with poorly controlled Human Immunodeficiency Virus infection. Clinical Infectious Diseases. 76(3). e522–e525. 35 indexed citations
9.
Tamandjou, Cynthia, et al.. (2021). Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review. BMC Cancer. 21(1). 715–715. 14 indexed citations
10.
Mokaya, Jolynne, Tongai Maponga, Anna McNaughton, et al.. (2020). Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults. Journal of Clinical Virology. 129. 104548–104548. 18 indexed citations
11.
McNaughton, Anna, José Lourenço, Phillip Armand Bester, et al.. (2020). Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis. PLoS Medicine. 17(4). e1003068–e1003068. 40 indexed citations
12.
Geffert, Karin, Tongai Maponga, Wolfgang Preiser, et al.. (2020). Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional study. BMC Infectious Diseases. 20(1). 395–395. 12 indexed citations
13.
Maponga, Tongai, Richard H. Glashoff, Barbara Robertson, et al.. (2020). Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV. BMC Gastroenterology. 20(1). 226–226. 14 indexed citations
14.
Maponga, Tongai, et al.. (2019). Sustainable development goals for HBV elimination in South Africa: Challenges, progress, and the road ahead. Oxford University Research Archive (ORA) (University of Oxford). 17. 15–25. 4 indexed citations
15.
Mokaya, Jolynne, Anna McNaughton, Tongai Maponga, et al.. (2018). A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review. SHILAP Revista de lepidopterología. 3. 29–29. 61 indexed citations
16.
Mokaya, Jolynne, Anna McNaughton, Tongai Maponga, et al.. (2018). A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 3. 29–29. 52 indexed citations
17.
Maponga, Tongai, et al.. (2017). Racial differences in seroprevalence of HAV and HEV in blood donors in the Western Cape, South Africa: a clue to the predominant HEV genotype?. Epidemiology and Infection. 145(9). 1910–1912. 12 indexed citations
18.
Tamandjou, Cynthia, et al.. (2017). Is hepatitis B birth dose vaccine needed in Africa?. Pan African Medical Journal. 27(Suppl 3). 18–18. 19 indexed citations
19.
Scheller, Carsten, Stéfan du Plessis, Gabriele Arendt, et al.. (2013). Increases in CSF dopamine in HIV patients are due to the dopamine transporter 10/10-repeat allele which is more frequent in HIV-infected individuals. Journal of Neural Transmission. 120(10). 1411–1419. 21 indexed citations
20.
Maponga, Tongai, Samreen Ijaz, Josephine Barnes, et al.. (2013). The epidemiology of hepatitis B virus infection in HIV-infected and HIV-uninfected pregnant women in the Western Cape, South Africa. Vaccine. 31(47). 5579–5584. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgina Ireland Breakdown of academic impact, for papers by Clement Gascua Adu-Gyamfi Breakdown of academic impact, for papers by Joan M. Block Breakdown of academic impact, for papers by Meredith Reilly Breakdown of academic impact, for papers by Linh‐Vi Le Breakdown of academic impact, for papers by Yi‐Chia Huang Breakdown of academic impact, for papers by Diane Goodwin Breakdown of academic impact, for papers by Kristin Sweet Breakdown of academic impact, for papers by Xiaoying Ma Breakdown of academic impact, for papers by Gyde Steffen
Rankless by CCL
2026